RO4995819

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for RO4995819, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment [Phase 2]

See pricing